Case Study
Monday, September 23
04:00 PM - 04:30 PM
Live in Berlin
Less Details
Mid-sized Contract Development and Manufacturing Organizations (CDMOs) face increasing pressure to enhance operational efficiency while ensuring regulatory compliance. This presentation explores the implementation of a modular Manufacturing Execution System (MES) as a strategic approach to digitization that transcends mere compliance. By adopting a flexible, scalable MES framework, PharmaPath streamlined production processes, improved data integrity, and fostered real-time decision-making. The session highlights key benefits such as enhanced traceability, reduced time-to-market, and improved resource allocation. Furthermore, it discusses the phased implementation approach, focusing on quick wins and offering best practices for successful integration.
Panagiotis Tsiveriotis Ph.D. is the Chief Industrial Officer at PharmaPath. During his more than 25 years in Pharma he held different leadership positions in R&D and manufacturing in various mid-size of big multinational companies. Over the years, he led several transformation projects combining strong leadership with deep knowledge of pharma operations.